Bavarian Nordic’s shares experienced a surge this week following the World Health Organization’s (WHO) declaration of a public health emergency for mpox and the company’s announcement that it could provide 10 million doses of the vaccine. CEO Paul Chaplin told Bloomberg that his firm has 300,000 doses ready to distribute immediately, with potentially 2 million more available by the end of next year. Africa Centres for Disease Control and Prevention (Africa CDC) previously stated it needed 10 million doses to address an mpox outbreak that has spread from the Democratic Republic of the Congo to other African countries. WHO officials say this strain appears to be more deadly than another variant that caused a worldwide outbreak in 2022 and 2023. Over the past five days, Bavarian Nordic’s stock value increased by approximately 49%, raising it to about $14.11 per share as of Friday afternoon.
